Pre-Market Briefing — 2026-05-15
May 15, 2026Pre-Market Briefing — 2026-05-15
Market Regime
QQQ $714.71 — +13.9% vs SMA50 ($627.28) · Risk On ✅
Portfolio
| Strategy | Value | Return | DD | Positions | Cash |
|---|---|---|---|---|---|
| 4-Pool | $1,947,942 | +1847.9% | -2.0% | 20 | 0% |
| V5.3 | $1,194,777 | +1094.8% | 0.0% | 19 | 0% |
Breakout Signals
No breakout signals today.
_Section section_options_radar unavailable.
Open Positions
| Ticker | Entry | Current | Gain% | Strategy |
|---|---|---|---|---|
| 000660.KS | $611.02 | $1442.34 | +136.1% | 4-Pool |
| 0981.HK | $8.21 | $9.53 | +16.1% | 4-Pool |
| 1347.HK | $12.06 | $16.68 | +38.3% | 4-Pool |
| 2513.HK | $102.10 | $147.81 | +44.8% | 4-Pool |
| APLD | $32.19 | $45.48 | +41.3% | 4-Pool |
| APP | $433.51 | $453.53 | +4.6% | 4-Pool |
| AVGO | $402.17 | $416.79 | +3.6% | 4-Pool |
| CIEN | $67.36 | $577.90 | +757.9% | 4-Pool |
| CIFR | $15.42 | $21.24 | +37.7% | 4-Pool |
| GFS | $47.80 | $74.99 | +56.9% | 4-Pool |
| LITE | $62.86 | $1030.37 | +1539.2% | 4-Pool |
| LRCX | $246.49 | $295.44 | +19.9% | 4-Pool |
| MDB | $264.69 | $303.00 | +14.5% | 4-Pool |
| MP | $57.36 | $63.73 | +11.1% | 4-Pool |
| MU | $465.66 | $803.63 | +72.6% | 4-Pool |
| NOK | $11.30 | $14.71 | +30.2% | 4-Pool |
| PWR | $317.65 | $773.72 | +143.6% | 4-Pool |
| TER | $107.65 | $363.38 | +237.6% | 4-Pool |
| TSM | $365.90 | $399.80 | +9.3% | 4-Pool |
| WULF | $18.05 | $23.12 | +28.1% | 4-Pool |
| 000660.KS | $611.02 | $1442.34 | +136.1% | V5.3 |
| 005930.KS | $138.98 | $207.30 | +49.2% | V5.3 |
| 0981.HK | $8.21 | $9.53 | +16.1% | V5.3 |
| 9888.HK | $15.68 | $17.67 | +12.7% | V5.3 |
| ASML | $1421.05 | $1581.58 | +11.3% | V5.3 |
| CCJ | $115.90 | $115.39 | -0.4% | V5.3 |
| CIEN | $67.36 | $577.90 | +757.9% | V5.3 |
| CIFR | $15.42 | $21.24 | +37.7% | V5.3 |
| CRDO | $119.59 | $189.36 | +58.3% | V5.3 |
| ETN | $400.44 | $406.94 | +1.6% | V5.3 |
| FCX | $49.15 | $67.16 | +36.6% | V5.3 |
| GFS | $47.80 | $74.99 | +56.9% | V5.3 |
| GOOGL | $317.24 | $402.62 | +26.9% | V5.3 |
| LRCX | $246.49 | $295.44 | +19.9% | V5.3 |
| MDB | $264.69 | $303.00 | +14.5% | V5.3 |
| PWR | $317.65 | $773.72 | +143.6% | V5.3 |
| QCOM | $156.00 | $213.17 | +36.6% | V5.3 |
| TSM | $365.90 | $399.80 | +9.3% | V5.3 |
| UMC | $12.98 | $15.92 | +22.7% | V5.3 |
X Alpha — Analyst Chatter
Convergence Alerts — X + Breakout Scanner
| Ticker | Direction | Source | Breakout | Score | Thesis |
|---|---|---|---|---|---|
| NVDA | Long | @jukan05 | VCP | 50 | H200 approved in China |
1. MACRO & THEMATIC OVERVIEW
Dominant themes: (1) Undervalued CPO/SiPh supply chain bottlenecks for AI hyperscalers ($NVDA/$TSM/AMZN Trainium), with $FOCI repeatedly flagged as mispriced vs. $POET at similar ~$3B MCs despite superior positioning; (2) $SIVE expansion via AlChip/$AMZN private placement and Ayar Labs ties, amplifying MSCI inflows; (3) Robotics/humanoid BOM components, China-dominant (Leader Drive/Sanhua for $TSLA Optimus) but Japan alternatives (Harmonic Drive) as geopolitical hedges. Analysts connect CPO ramp to 2027/2028 revenue visibility, echoing prior mispricings like $AXTI; robotics emphasizes mass-production cost edges in China.
2. HIGH-CONVICTION IDEAS
$FOCI (3363) — CPO Bottleneck Undervalued vs. $POET
- Who: @aleabitoreddit (semi supply chain expert)
- Thesis: $FOCI (~$3.1B MC) is the bottleneck for CPO volume ramp and main supplier to $TSM/$NVDA, with massive BOM relative to MC and dominant share expected 2027/2028; bafflingly valued lower than $POET ($3.14B MC) despite superior positioning—high conviction institutional outperformance once discovered.
- Key data: $3.1B MC vs. $POET $3.14B; CPO revenue visibility 2027/2028.
- Valuation: ~$3B MC undervalues future CPO TAM dominance.
- Catalyst: Institutions discovering name (like $AXTI last year); management pursues M&A.
- Engagement: 667; 429
- Contrarian?: Yes—challenges $POET premium.
- Cross-references: Implicit bearish on $POET; aligns with Shunsin CPO/SiPh ramp.
$SIVE — AlChip/$AMZN Trainium Design Win + MSCI Inflow
- Who: @aleabitoreddit (optics/semi IP expert)
- Thesis: New $AMZN-AlChip private placement implies Trainium design wins via AlChip (Ayar Labs' lead customer, where $SIVE fits); more bullish than $POET's $50M→$500M order; MSCI tens of millions inflow imminent.
- Key data: MSCI inflow in ~2 weeks (by ~2026-05-29); M&A for optical TAM expansion (like $LITE).
- Valuation: N/A.
- Catalyst: MSCI rebalance; market connects Ayar/AlChip/$SIVE chain.
- Engagement: 673; 84; 62
- Contrarian?: No—builds on positive news flow.
- Cross-references: $SIVE supply chain > $POET per analyst.
Shunsin (6451) — CPO/SiPh Thesis Inflecting
- Who: @aleabitoreddit (semi supply chain expert)
- Thesis: CPO/SiPh exposure starting to play out after 1-month lag, mirroring $IQE→$SOI pattern where theses randomly +up ~1 month post-post (possible institutional copy-trading).
- Key data: Thesis posted ~2026-04-15; now inflecting.
- Valuation: N/A.
- Catalyst: Ongoing supply chain validation.
- Engagement: 402
- Contrarian?: No—confirmation of prior call.
- Cross-references: Ties to broader CPO theme with $FOCI.
Harmonic Drive (6324) / Leader Drive / Sanhua — Robotics BOM Leaders
- Who: @aleabitoreddit (robotics components expert)
- Thesis: Harmonic Drive (~$4.2B MC) leads West in harmonic reduction gears (large humanoid BOM part); prefers cheaper Leader Drive for mass production; Sanhua for $TSLA Optimus—China dominates robotics components for cost/mass production, Japan as US alternative.
- Key data: Harmonic ~$4.2B MC.
- Valuation: Leader Drive cheaper for scale.
- Catalyst: $TSLA Optimus ramp; geopolitical supply shifts.
- Engagement: 566; 213 (reply)
- Contrarian?: Yes—China edge vs. Japan premium.
- Cross-references: None opposing.
$NBIS — Compounder Like $AMZN/$GOOGL
- Who: @aleabitoreddit (long-term growth analyst)
- Thesis: Unless thesis breaks, $NBIS can sustain growth like $AMZN/$GOOGL over 15 years; trims trigger taxes often exceeding corrections, favoring HODL.
- Key data: 15-year $AMZN/$GOOGL analogy.
- Valuation: N/A.
- Catalyst: N/A—structural.
- Engagement: 218
- Contrarian?: Yes—against trimming momentum.
- Cross-references: None.
3. SUPPLY CHAIN & SECTOR MAP
- CPO/SiPh for AI: $FOCI (3363) → $TSM/$NVDA (CPO bottleneck, dominant 2027/2028); Shunsin (6451) CPO/SiPh; $SIVE → Ayar Labs → AlChip → $AMZN Trainium (design wins via private placement > $POET $50M→$500M order); echoes $AXTI mispricing last year, $IQE→$SOI, $LITE optical TAM expansion.
- Robotics/Humanoid BOM: China cluster (Leader Drive mass-prod cost leader, Sanhua for $TSLA Optimus, majority Tesla vendors) vs. Japan (Harmonic Drive (6324) Western leader in gears).
- Valuation Anomalies: $FOCI ($3.1B) < $POET ($3.14B) despite superior CPO positioning.
4. RISK & CATALYST WATCH
- 2026-05-29 (~2 weeks): $SIVE MSCI tens of millions inflow.
- 2027/2028: $FOCI CPO revenue from $NVDA/$TSM ramps.
- Near-term: Shunsin CPO/SiPh inflection (1-month thesis lag); institutions discovering $FOCI; $SIVE M&A for optics expansion.
- Geopolitical: US firms pivot to Japan robotics (e.g., Harmonic Drive) amid China dominance.
- No explicit risks flagged beyond thesis breaks for $NBIS.
5. SIGNAL TABLE
| Ticker | Handle | Direction | Signal Type | Engagement | Thesis |
|---|---|---|---|---|---|
| FOCI | @aleabitoreddit | bullish | early_trend | 667 | $3.1B MC bottleneck for $TSM/$NVDA CPO ramp, undervalued vs $POET $3.14B |
| FOCI | @aleabitoreddit | bullish | confirmation | 429 | ~$3B MC with massive CPO BOM, dominant $NVDA/$TSM share 2027/2028 |
| SIVE | @aleabitoreddit | bullish | catalyst | 673 | $AMZN-AlChip placement implies Trainium wins via Ayar + MSCI inflow ~5/29 |
| SIVE | @aleabitoreddit | bullish | confirmation | 84 | M&A expands optical TAM like $LITE, not bonuses |
| Shunsin | @aleabitoreddit | bullish | inflection | 402 | CPO/SiPh thesis inflecting 1mo post-post like $IQE/$SOI |
| POET | @aleabitoreddit | bearish | early_trend | 667 | $3.14B MC > FOCI despite inferior CPO positioning |
| Harmonic Drive | @aleabitoreddit | bullish | early_trend | 566 | ~$4.2B MC Western gear leader in robotics BOM |
| NBIS | @aleabitoreddit | bullish | confirmation | 218 | Sustains growth like 15yr $AMZN/$GOOGL, trims inefficient vs taxes |
| AXTI | @aleabitoreddit | bullish | confirmation | 62 | Prior CPO mispricing analog for $FOCI |
No substantive investment-related posts from the specified analysts ( @_thevalueist, @antonlavay, @bearhunter, @bickerinbrattle, @bluechipdaily, @chartmaster, @concodanomics, @dampedspring, @dirtcheapstocks, @discountedtf) in the last 24 hours matching the criteria (original posts since 2026-05-14).
No substantive posts from the specified analysts in the last 24 hours.
No substantive posts from the specified analysts in the last 24 hours.
No substantive posts from the specified analysts in the last 24 hours.
Signal Book
| Ticker | Direction | Source | Thesis |
|---|---|---|---|
| AXTI | Long | @aleabitoreddit | Prior CPO mispricing analog for $FOCI |
| NBIS | Long | @aleabitoreddit | Sustains growth like 15yr $AMZN/$GOOGL, trims inefficient vs taxes |
| POET | Short | @aleabitoreddit | $3.14B MC > FOCI despite inferior CPO positioning |
| SHUNSIN | Long | @aleabitoreddit | CPO/SiPh thesis inflecting 1mo post-post like $IQE/$SOI |
| SIVE | Long | @aleabitoreddit | $AMZN-AlChip placement implies Trainium wins via Ayar + MSCI inflow ~5/29 |
| FOCI | Long | @aleabitoreddit | $3.1B MC bottleneck for $TSM/$NVDA CPO ramp, undervalued vs $POET $3.14B |
| CRBS | Short | @aleabitoreddit | Likes but not at $70B valuation. |
| CBRS | Short | @aleabitoreddit | Not at $90-100B MC post-IPO float disconnect like $CRCL/$BULL. |
| AMAT | Long | @aleabitoreddit | Presidential semi supply ETF long from $JBL to $AMAT. |
| JBL | Long | @aleabitoreddit | Presidential semi supply ETF long from $JBL to $AMAT. |
| AMAT | Long | @jukan05 | Broad portfolio enables bundled solutions edge |
| INTEL | Long | @jukan05 | Apple TSMC orders provide complete/large-scale foundry training |
| SIVE | Long | @aleabitoreddit | Captures large % of $POET $500M BOM laser orders |
| POET | Long | @aleabitoreddit | Warrants drive $500M extra purchase orders |
| NVDA | Long | @jukan05 | H200 approved in China |